Latin America Investor Daily
SEE OTHER BRANDS

Get your fresh news on finance and banking in Latin America

Latin America Investor Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.

Press releases published on May 16, 2025

NMDP℠ Partners with Lil Miquela to Encourage Young People to Join the Blood Stem Cell Donor Registry and Help Save Patient Lives

NMDP℠ Partners with Lil Miquela to Encourage Young People to Join the Blood Stem Cell Donor Registry and Help Save Patient Lives

MINNEAPOLIS, May 16, 2025 (GLOBE NEWSWIRE) -- NMDP℠ (formerly Be The Match®/National Marrow Donor Program), which operates the world’s most diverse registry of blood stem cell and marrow donors, has launched its first virtual influencer campaign to engage …

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference

Fort Lee, NJ, May 16, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious …

Willis Lease Finance Corporation Appoints Z. Clifton Dameron as General Counsel

Willis Lease Finance Corporation Appoints Z. Clifton Dameron as General Counsel

COCONUT CREEK, Fla., May 16, 2025 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and global provider of aviation services, is pleased to announce the internal …

WTW Announces Regular Quarterly Dividend

WTW Announces Regular Quarterly Dividend

LONDON, May 16, 2025 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, announced that its Board of Directors approved a regular quarterly cash dividend of $0.92 per common share for the quarter ended March 31, …

Bit Origin Ltd Announces Court Hearing on June 5, 2025, for Share Capital Reduction

Bit Origin Ltd Announces Court Hearing on June 5, 2025, for Share Capital Reduction

NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ: BTOG) ("Bit Origin" or the "Company"), an emerging growth company engaged in the crypto mining business with diversified expansion strategies, today announced that a court hearing will be …

Royalty Pharma Completes the Acquisition of Its External Manager

Royalty Pharma Completes the Acquisition of Its External Manager

NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has successfully closed the acquisition of its external manager, RP Management, LLC (“RP Management”). The acquisition received overwhelming support from …

Bunker Hill Announces Updates to Equity Financings and Major Capital Restructuring

Bunker Hill Announces Updates to Equity Financings and Major Capital Restructuring

KELLOGG, Idaho and VANCOUVER, British Columbia, May 16, 2025 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR |OTCQB: BHLL) is pleased to announce total funding of US$10.3 million, including a cash order book for …

Ryman Hospitality Properties, Inc. to Present at the 2025 REITweek Conference – Wednesday, June 4, 2025, 11:45 a.m. ET

Ryman Hospitality Properties, Inc. to Present at the 2025 REITweek Conference – Wednesday, June 4, 2025, 11:45 a.m. ET

NASHVILLE, Tenn., May 16, 2025 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (“RHP”), a leading lodging and hospitality real estate investment trust that specializes in group-oriented, upscale convention center resorts and country …

Silo Pharma Announces Closing of $2 Million Public Offering

Silo Pharma Announces Closing of $2 Million Public Offering

SARASOTA, FL, May 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, closed on the previously announced public …

Azimut Closes $8.7 Million Private Placement

Azimut Closes $8.7 Million Private Placement

LONGUEUIL, Québec, May 16, 2025 (GLOBE NEWSWIRE) -- Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to report that on May 16, 2025, it has closed its previously announced non-brokered placement with Centerra Gold …

Azimut clôture un placement privé de 8,7 millions $

Azimut clôture un placement privé de 8,7 millions $

LONGUEUIL, Québec, 16 mai 2025 (GLOBE NEWSWIRE) -- Exploration Azimut Inc. (« Azimut » ou la « Société ») (TSXV : AZM) (OTCQX : AZMTF) a le plaisir d’annoncer que le 16 mai 2025, elle a clôturé le placement privé sans intermédiaire précédemment annoncé …

Coca-Cola Consolidated’s 10-for-1 Stock Split Finalized; Shares to Trade on Split-Adjusted Basis May 27, 2025

Coca-Cola Consolidated’s 10-for-1 Stock Split Finalized; Shares to Trade on Split-Adjusted Basis May 27, 2025

CHARLOTTE, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- Coca‑Cola Consolidated, Inc. (NASDAQ: COKE) today announced that its 10-for-1 split of the Company’s Common Stock and Class B Common Stock has been approved by its stockholders, and shares of the Company’s …

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …

Covenant Logistics Group Announces Quarterly Cash Dividend

Covenant Logistics Group Announces Quarterly Cash Dividend

CHATTANOOGA, Tenn., May 16, 2025 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. (NYSE: CVLG) (“Covenant” or the “Company”) announced today that its board of directors has declared a quarterly cash dividend of $0.07 per share of Class A and Class B …

Titan Machinery Completes Acquisition of Farmers Implement & Irrigation

Titan Machinery Completes Acquisition of Farmers Implement & Irrigation

WEST FARGO, N.D., May 16, 2025 (GLOBE NEWSWIRE) -- Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, today announced that it has completed the acquisition of the dealership assets of …

Orange County Bancorp, Inc. Declares Cash Dividend

Orange County Bancorp, Inc. Declares Cash Dividend

MIDDLETOWN, N.Y., May 16, 2025 (GLOBE NEWSWIRE) -- Orange County Bancorp, Inc. (Nasdaq: OBT), parent company of Orange Bank …

Heidmar Announces the Availability of Its 2024 Annual Report on Form 20-F

Heidmar Announces the Availability of Its 2024 Annual Report on Form 20-F

ATHENS, Greece and NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Heidmar Maritime Holdings Corp. (the "Company" or "Heidmar") (NASDAQ: HMR), today announced that its annual report on Form 20-F (the “Annual Report”), which includes the Company’s audited …

AirNet Received Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency

AirNet Received Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency

BEIJING, May 16, 2025 (GLOBE NEWSWIRE) -- AirNet Technology Inc. ("AirNet" or the "Company") (Nasdaq: ANTE), today announced that on May 13, 2025, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock …

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, May 16, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, May 16, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service